Erasca named Charles S. Fuchs president of research and development, effective immediately.
Fuchs most recently served as chief medical officer at Tubulis, where he led clinical strategy and pipeline development.
He previously held senior oncology drug development roles at Genentech and Roche, following earlier leadership posts at Yale Cancer Center and Dana-Farber.
ERAS•
